Biopolym. Cell. 2010; 26(4):317-321.
Short Communications
Multisubunit complex eEF1H in human glial tumors: from mRNA to protein
1Veremieva M. V., 2Malysheva T. A., 2Zozulya Y. P., 2Rozumenko V. D., 1Sidorik L. L., 1Kavsan V. M., 1Negrutskii B. S., 1El'skaya A. V.
  1. Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680
  2. Institute of Neurosurgery named after A. P. Romodanov, NAMS of Ukraine
    32, Manuilskogo Str., Kyiv, Ukraine, 04050


Aim. To investigate protein level of all subunits of the eukaryotic elongation translation factor eEF1H (eEF1A, eEF1Bα, eEF1Bβ and eEF1Bγ) in glial tumors of human brain in comparison with normal brain. Methods. The eEF1H components content has been investigated in human glioblastoma clinical samples by Western blot analysis. Results. To determine the eEF1Bα, eEF1Bβ and eEF1Bγ content, the polyclonal antibodies against all eEF1H subunits were obtained. The tendency of the eEF1Bγ protein level to increase in glioblastomas was observed. There were no significant differences in the eEF1A, eEF1Bα and eEF1Bβ protein contents. Conclusions. In the previous report we analysed the expression of all eEF1H subunits in human glial brain tumor on the mRNA level. This study showed that eEF1Bγ was overexpressed while no significant changes in other eEF1H subunits were observed. It suggests a possible function of eEFBγ which is cancer-related and is not connected with the functioning of eEF1H complex in translation.
Keywords: translation elongation factor eEF1H, human glial brain tumors


[1] Negrutskii B. S., El'skaya A. V. Eukaryotic translation elongation factor 1a: structure, expression, functions, and possible role in aminoacyl-tRNA channeling Prog. Nucl. Acid Res. Mol. Biol 1998 60:47–78.
[2] IUMBMB. Prokaryotic and eukaryotic translation factors. Ad Hoc Nomenclature Subcommittee Report. Biochimie 1996 78, N 11–12:1119–1122.
[3] Joseph P., O'Kernick C., Othumpangat S., Lei Y., Yuan B., Ong T. Expression profile of eukaryotic translation factors in human cancer tissues and cell lines Mol. Carcinogen 2004 40, N 3:171–179.
[4] Ogawa K., Utsunomiya T., Mimori K., Tanaka Y., Inoue H., Murayama S., Mori M. Clinical significance of elongation factor-1 delta mRNA expression in oesophageal carcinoma. Br. J. Cancer. 2004; 91, N 2:282–286.
[5] Ender B., Lynch P., Kim Y. H., Inamdar N. Y., Cleary K. R., Frazier M. L. Overexpression of an elongation factor-1 gamma-hybridizing RNA in colorectal adenomas Mol. Carcinogen 1993 7, N 1:18–20.
[6] De Bortoli M., Castellino R. C., Lu X. Y., Deyo J., Sturla L. M., Adesina A. M., Perlaky L., Pomeroy S. L., Lau C. C., Man T. K., Rao P. H., Kim J. Y. Medulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8 BMC Cancer 2006 6:223.
[7] Robert F., Carrier M., Rawe S., Chen S., Lowe S., Pelletier J. Altering chemosensitivity by modulating translation elongation PloS One 2009 4, N 5 e5428.
[8] Veremieva M., Shostak K., Malysheva T., Zozulya Y., Rozumenko V., Kavsan V., Negrutskii B. Expression of different subunits of eukaryotic translation elongation factor eEF1 in human glial brain tumors Biopolym. Cell. 2008 24, N 4 P. 310–317.
[9] Kleihues P., Cavenee W. K. World Health Organization classification of tumors of the nervous system Lyon: IARC/WHO, 2000.
[10] Maier T., Guell M., Serrano L. Correlation of mRNA and protein in complex biological samples FEBS Lett 2009 583, N 24:3966–3973.
[11] Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem 1976 72 P. 248–254.
[12] Al-Maghrebi M., Anim J. T., Olalu A. A. Up-regulation of eukaryotic elongation factor-1 subunits in breast carcinoma. Anticancer Res. 2005; 25:2573–2578.
[13] Chi K., Jones D., Frazier M. Expression of an elongation factor 1 gamma-related sequence in adenocarcinomas of the colon. Gastroenterology. 1992; 103, N 1:98–102.
[14] Mimori K., Mori M., Tanaka S., Akiyoshi T., Sugimachi K. The overexpression of elongation factor 1 gamma mRNA in gastric carcinoma. Cancer 1995 75, N 6 (Suppl.) P. 1446–1449.
[15] Lew Y., Jones D., Mars W., Evans D., Byrd D., Frazier M. Expression of elongation factor-1 gamma-related sequence in human pancreatic cancer Pancreas 1992 7, N 2:144–152.
[16] Olarewaju O., Ortiz P. A., Chowdhury W. Q., Chatterjee I., Kinzy T. G. The translation elongation factor eEF1B plays a role in the oxidative stress response pathway RNA Biol 2004 1, N 2:89–94.